United States  

Trusted News Discovery Since 2008
One News Page
> >

Why Biogen’s Alzheimer’s Drug Presentation Left Investors Uninspired

Motley Fool Saturday, 7 December 2019
Biogen’s update on its investigative Alzheimer’s drug may not be the positive signal investors were hoping for.

You Might Like

Tweets about this

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.